University of California San Francisco
Give to UCSF
Two decades ago, children with stroke were falling into this gap between stroke providers who didn’t treat children and child neurologists who were uncomfortable with stroke. Today, UCSF is at the forefront of pediatric stroke care and research.
A study looked at how ultraprocessed foods (UPFs), like Lunchables, are designed—and why they may lead to overeating and weight gain. Using internal company documents, the study showed that Lunchables were influenced by strategies from the tobacco industry, specifically Philip Morris, which once owned Kraft.
Using AI on mammograms can identify patients at highest risk for breast cancer and get them same-day follow up care, eliminating stressful waiting times.
What a year to celebrate! The members of the class of 2023 have shown their resilience and dedication to advance health research and patient care in ways we never imagined a few years ago. Truly impressive. We celebrate you all!
UCSF research shows that international rules for biosimilars, mimics of biologic drugs like Ozempic and insulin, need to improve and match each another to encourage biosimilar development, testing, and approval. This would dramatically improve drug affordability just like generics has done.
About 6% of asymptomatic adults have a biomarker for Alzheimer's disease and are already showing very subtle signs of the disease that would not come to light in a standard cognitive test.
Mark Anderson, MD, PhD, a pioneer in diabetes research and professor of medicine at UCSF, has been elected to the National Academy of Sciences — one of the highest honors in American science.
A team at UCSF developed a multitask deep learning framework that can effectively predict Alzheimer’s disease diagnosis, cognitive scores, and future cognitive decline using only baseline MRI and demographics.
Pairing vulnerable, low-income patients with asthma coaches can improve outcomes and may also reduce costs associated with avoidable health care use.
In the last few years, progress has been made in the fight against Alzheimer’s disease with a class of therapies called anti-amyloid antibodies (anti-Aβ). These anti-Aβ therapies, like lecanumab
Jody Baron and Gabi Fragiadakis discover why some people with chronic Hepatitis B are cured after they're taken off of antiviral drugs, despite falling severely ill when the drug regiment stops.
UCSF expert Charles Chiu discusses rising measles cases, extreme contagiousness, and why 95% vaccination rates are vital for community safety.
Joe Bondy-Denomy solves a CRISPR caper: this is how a viral protein stows itself on protein factories in bacteria, and destroys a CRISPR protein, designed to kill viruses, while it's being made.
UCSF’s pharmacogenetics program uses DNA testing to personalize prescriptions, reducing side effects and ensuring the right drug and dose for every patient.
Six pairs of UC San Francisco faculty members and their PhD students have been awarded funding through the W. M. Keck Foundation’s inaugural Scholar-Fellow Bridge Initiative, a program designed to
Attendees at a community breakfast for Oakland faith leaders hosted by Nicholas Holmes and Oakland Mayor Lee discussed youth violence prevention initiatives and other community topics.
The University of California Board of Regents approved plans for the UCSF Bakar Ear & Hearing Institute, a new, state-of-the-art ear facility at UCSF’s Mission Bay campus, taking the first step to creating one of the world’s leading centers for advancing research and care for hearing and balance disorders.
Multiple clinical trials have shown that GLP-1s are safe and effective for patients with obesity, diabetes and cardiovascular conditions. New evidence shows that the drugs may also protect against neurological diseases, like dementia, Parkinson's, and substance use disorder.
A large team of scientists, found that a single dose of psilocybin created positive changes in the brain and well-being, one hour and one month after administration.
UCSF Health was named a top place to work by Becker's Healthcare.
UCSF Health is launching a special clinic for young adults with colorectal cancer, of which one in five cases now affects younger people, and is a leading cause of cancer death in people aged twenty to forty.
A $2.5 million gift by Ted W. Love and Joyce Y. Love to UCSF Benioff Children’s Hospitals will expand care for patients with sickle cell disease and support the building of new facilities at the campus.
A team of researchers discover how the <i>stentor</i>, an organism made of a single, gigantic cell, learns without a brain.
Epilepsy physicians Jon Kleen and Eddie Chang used high-resolution technology to see how cognition is disrupted in people with epilepsy and predict when it will occur. The new view points the way to being able to fend of these disruptions.
The American Association for the Advancement of Science, one of the world’s largest general scientific societies and publisher of the Science family of journals, named three UCSF faculty to the 2025 class of AAAS Honorary Fellows: Elissa Epel, Geeta Jayant Narlikar, and Donald Emil Ganem (emeritus).
A global team of scientists and clinicians found that a cheap, easy-to-use test for tuberculosis was just as good, if not better, at detecting disease than existing tests, shortening time to a diagnosis from days to just 15 minutes.
Discover how SF became the first city to use doxycycline to drop STI rates by up to 24%. UCSF experts explain the impact of doxy-PEP.
Newsweek names UCSF Health a top hospital for maternity care and reproductive care.
UCSF's Cherry Leung, associate professor of community health systems with the UC San Francisco School of Nursing, researches the gut-brain axis as a potential adjunct therapy for improving adolescent mental health.
Freeze-dried human platelets could be used as a "molecular tourniquet" for brain bleeds in the minutes to hours after a traumatic brain injury, according to a UCSF team led by Shibani Pati. The scientists envision stocking ambulances and EDs with the product.
